Who owns the DISRUPTING DISEASE trademark?

The DISRUPTING DISEASE trademark is owned by Alnylam Pharmaceuticals, Inc..

What class is the DISRUPTING DISEASE trademark registered in?

The DISRUPTING DISEASE trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for DISRUPTING DISEASE?

The USPTO serial number for DISRUPTING DISEASE is 98609018.

What is the registration number for DISRUPTING DISEASE?

DISRUPTING DISEASE is registered under USPTO registration number 7869579.

Sealvo

Home Search: DISRUPTING DISEASEDISRUPTING DISEASE #98609018

Back

Updated Oct 12, 2026·38 searches this week

View on USPTO TSDR Find similar marks

DIS

USPTO Trademark Record

REGISTERED

DISRUPTING DISEASE

SN 98609018·Reg 7869579·Filed Jun 19, 2024

Owner Alnylam Pharmaceuticals, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

DISRUPTING DISEASE (Serial No. 98609018), Registration No. 7869579, is a registered US trademark filed on Jun 19, 2024 by Alnylam Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: July 15, 2031

Mark Intelligence

DISRUPTING DISEASE (Reg. #7869579) is a registered US trademark that has been protecting its owner, Alnylam Pharmaceuticals, Inc., since 2024. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

Jun 19, 2024

SERIAL

98609018

REG#

7869579

REGISTERED

Jul 15, 2025

Filing Information

StatusREGISTERED

Filing DateJun 19, 2024

Serial Number98609018

Registration No.7869579

Registration DateJul 15, 2025

Status DateJul 15, 2025

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application Currently

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1802254

480Jul 03, 2024

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Mar 31, 2022

First use in commerce: Mar 31, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

21 events

REGISTERED-SUPPLEMENTAL REGISTER

Jul 15, 2025

REGISTERED-SUPPLEMENTAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 15, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Jun 13, 2025

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 14, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 14, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 14, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Feb 21, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 21, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 21, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 25, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 25, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 25, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Oct 29, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 29, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 29, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Oct 29, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 29, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 29, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 23, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Jun 19, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 19, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Alnylam Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

ONP

ONPATTRO

88637585

Alnylam Pharmaceuticals, Inc.

REGISTERED

LOG

LogoMark

88799212

Alnylam Pharmaceuticals, Inc.

REGISTERED

RNA

RNAI REVOLUTION

98603908

Alnylam Pharmaceuticals, Inc.

REGISTERED

GIV

GIVLAARI

87784738

Alnylam Pharmaceuticals, Inc.

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

DIS

DISRUPTING SWAP

98687041

TAGORETECH, INC.

REGISTERED

DIS

DISEASE CANCELLING

88982289

Immuneering Corporation

REGISTERED

DIS

DISEASE ELIMINATION

86509756

Dr. Julio Montaner

REGISTERED

ALZ

ALZHEIMER'S DISEASE RESEARCH

86168764

BrightFocus Foundation

REGISTERED

Other Marks by Jennifer Kwon

Additional USPTO filings handled by the same attorney of record.

ADH

ADHD + ME

99674433

REGISTERED

ITO

ITO INTERNATIONAL TRAVEL ORGANIZATION

98780378

REGISTERED

SOU

SOUTHERN CHARM MEETS EUROPEAN STYLE

98369141

REGISTERED

JOE

JOEI SMOKELESS

98815857

REGISTERED

DISRUPTING DISEASE

Run a conflict check

Other Marks by Alnylam Pharmaceuticals, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Jennifer Kwon

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company